Literature DB >> 4569057

Treatment of Ewing's sarcoma with adriamycin (NSC-123127).

R K Oldham, T C Pomeroy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4569057

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN: 0069-0112


× No keyword cloud information.
  7 in total

Review 1.  Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors.

Authors:  Daniel M Green; Larry E Kun; Katherine K Matthay; Anna T Meadows; William H Meyer; Paul A Meyers; Sheri L Spunt; Leslie L Robison; Melissa M Hudson
Journal:  Pediatr Blood Cancer       Date:  2013-02-15       Impact factor: 3.167

2.  Ewing sarcoma and related FET family translocation-associated round cell tumors: A century of clinical and scientific progress.

Authors:  Robert G Maki; Patrick J Grohar; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2022-04-30       Impact factor: 4.263

3.  Bone sarcoma: success through interdisciplinary collaboration.

Authors:  Stefanie Hecker-Nolting; Ana Maia Ferreira; Stefan S Bielack
Journal:  J Child Orthop       Date:  2021-08-20       Impact factor: 1.548

Review 4.  Ewing's sarcoma: standard and experimental treatment options.

Authors:  Vivek Subbiah; Pete Anderson; Alexander J Lazar; Emily Burdett; Kevin Raymond; Joseph A Ludwig
Journal:  Curr Treat Options Oncol       Date:  2009-06-17

5.  Inhibition by adriamycin of calmodulin-sensitive and phospholipid-sensitive calcium-dependent phosphorylation of endogenous proteins from heart.

Authors:  N Katoh; B C Wise; R W Wrenn; J F Kuo
Journal:  Biochem J       Date:  1981-07-15       Impact factor: 3.857

6.  Comparative immunotoxicity of free doxorubicin and doxorubicin encapsulated in cardiolipin liposomes.

Authors:  A Rahman; A Ganjei; J R Neefe
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

7.  Immunotoxicity of multiple dosing regimens of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes.

Authors:  A Rahman; A Joher; J R Neefe
Journal:  Br J Cancer       Date:  1986-09       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.